A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

[The effectiveness of short and prolonged course treatment of anxiety with Anvifen]. | LitMetric

Objective: To determine the effectiveness of the treatment of anxiety disorder with Anvifen (aminophenylbutyric acid) in a short (21 days) and prolonged (60 days) course of treatment.

Material And Methods: Patients were randomly divided into two groups: a short course (21 days) of treatment with Anvifen (group 1) and a prolonged course (60 days) of treatment with Avifen (group 2). In each group, patients were divided into age subgroups: 20-40 years old (1a - =30, mean age 32 [21; 39], 2a - =30, mean age 33 [23; 38] years) and 41-70 years (1b - =30, mean age 62 [51; 67] years; 2b - =30, mean age 60 [51; 68] years). Evaluated by: Hospital Anxiety and Depression Scale (HADS); fatigue according to the Russian version of the fatigue assessment scale (The Fatigue Assessment Scale - FAS); sleep assessment according to the questionnaire for scoring the subjective characteristics of sleep (sleep assessment - OS); mean frequency per month of attacks meeting the criteria for a panic attack (PA) in the previous 6 months; a comprehensive assessment of the severity of all subjective symptoms on a 10-point numerical rank scale (NRS), where «0» corresponded to the complete absence of any significant subjective symptoms, «10» - the maximum degree of bodily and mental discomfort presented by the patient. Anvifen patients took at a dose of 500 mg three times a day. The evaluation of the studied parameters was carried out at the point «1» (before the start of treatment), at point «2» at the end of the course of treatment (for group 1 - on the 21st day of treatment, for group 2 - on the 60th day of treatment), at point «3» (30 days after the end of treatment for patients in both groups).

Results: The indicators of subgroups 1a and 1b at point 2 had a significant positive trend (<0.05) compared with the indicators at point 1, but at point 3 these indicators did not differ significantly (>0.05). The indicators of subgroups 2a and 2b at point 2 had a significant positive trend (<0.05) compared with the indicators at point 1, and these differences persisted at point 3 (<0.05).

Conclusion: Anvifen effectively eliminates anxiety symptoms, but the effect of a short course lasts less than 1 month, the effect of prolonged treatment lasts more than 1 month. The authors recommend prolonged treatment of anxiety with Anvifen for at least 2 months.

Download full-text PDF

Source
http://dx.doi.org/10.17116/jnevro202212212168DOI Listing

Publication Analysis

Top Keywords

=30 age
16
days treatment
12
years =30
12
treatment
9
prolonged course
8
course treatment
8
treatment anxiety
8
course days
8
age [51
8
fatigue assessment
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!